A dysfunctional GCL will result in insufficient Glyteine being produced for the glutathione synthase enzyme to convert into glutathione
Olgun-Araneda V, Banawas S, Sarker MR, Paredes-Sabja D
Clin Exp Nephrol (2021) 25:10516
A method for increasing circulating and/or intracellular levels of glutathione, comprising: administering, to an individual in need thereof, an effective amount of S-acetyl-glutathione (SAG) in the form of delayed-release composition
This combination includes CJC-1295 , a growth hormone releasing hormone (GHRH) analogue, together with Ipamorelin , a selective growth hormone secretagogue
This isnt required, but it can smooth the screening process